634
Views
1
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Chemotherapy maintenance: An option for prolonged survival in malignant peritoneal mesothelioma?

, &
Pages 125-127 | Received 22 May 2009, Accepted 01 Jun 2009, Published online: 02 Nov 2009

Figures & data

Figure 1. Contrast-enhanced axial CT image during the portal venous phase demonstrates the MPeM (arrow) located in the left upper quadrant of the abdomen. Please note the broad attachment of the tumor to the stomach.

Figure 1. Contrast-enhanced axial CT image during the portal venous phase demonstrates the MPeM (arrow) located in the left upper quadrant of the abdomen. Please note the broad attachment of the tumor to the stomach.

Figure 2. Contrast-enhanced axial CT image during the portal venous phase shows complete regression of the MPeM in the left upper quadrant of the abdomen consistent with adequate response to chemotherapy.

Figure 2. Contrast-enhanced axial CT image during the portal venous phase shows complete regression of the MPeM in the left upper quadrant of the abdomen consistent with adequate response to chemotherapy.

Figure 3. Malignant peritoneal mesothelioma, epitheloid variant. Tumor architecture is partially papillary, partially tubular with solid components (H&E). Positive staining for CK5/6 and Calretinin. Negative staining for Ber-EP4. Low proliferation rate (MIB-1 staining not shown).

Figure 3. Malignant peritoneal mesothelioma, epitheloid variant. Tumor architecture is partially papillary, partially tubular with solid components (H&E). Positive staining for CK5/6 and Calretinin. Negative staining for Ber-EP4. Low proliferation rate (MIB-1 staining not shown).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.